Výsledky vyhledávání - "Joost H. C. M. Kreijtz"

Akademický článek

Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases

Autor: Arwen F. Altenburg, Joost H. C. M. Kreijtz, Rory D. de Vries, Fei Song, Robert Fux, Guus F. Rimmelzwaan, Gerd Sutter, Asisa Volz

Publikováno v: Viruses, Vol 6, Iss 7, Pp 2735-2761 (2014)

Respiratory viruses infections caused by influenza viruses, human parainfluenza virus (hPIV), respiratory syncytial virus (RSV) and coronaviruses are an eminent threat for public health. Currently, there are no licensed vaccines available for hPIV, R

Externí odkaz: https://doaj.org/article/ce4dd81d53d1421d889e1886836f84f1

Zobrazit plný text záznamu

Akademický článek

Evasion of Influenza A Viruses from Innate and Adaptive Immune Responses

Autor: Guus F. Rimmelzwaan, Joost H. C. M. Kreijtz, Carolien E. van de Sandt

Publikováno v: Viruses, Vol 4, Iss 9, Pp 1438-1476 (2012)

The influenza A virus is one of the leading causes of respiratory tract infections in humans. Upon infection with an influenza A virus, both innate and adaptive immune responses are induced. Here we discuss various strategies used by influenza A viru

Externí odkaz: https://doaj.org/article/7603b9bd923a42389ded30007525a1c0

Zobrazit plný text záznamu

Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara–Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial

Autor: Mart M. Lamers, Stella E. van Trierum, Arwen F. Altenburg, Nella J. Nieuwkoop, Joost H. C. M. Kreijtz, Albert D. M. E. Osterhaus, Marion Koopmans, Mathilde Richard, Gerd Sutter, Ron A. M. Fouchier, David F. Nieuwenhuijse, Rory D. de Vries, Erwin de Bruin, Mark Pronk, Guus F. Rimmelzwaan

Publikováno v: Journal of Infectious Diseases, 218(4), 614-623. Oxford University Press

BACKGROUND: High-pathogenicity avian influenza viruses continue to circulate in poultry and wild birds and occasionally infect humans, sometimes with fatal outcomes. Development of vaccines is a priority to prepare for potential pandemics but is comp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7af43a663d84667fbab1c267718f9e1
https://doi.org/10.1093/infdis/jiy214

Zobrazit plný text záznamu

Akademický článek

Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.

Autor: Rogier Bodewes, Joost H C M Kreijtz, Chantal Baas, Martina M Geelhoed-Mieras, Gerrie de Mutsert, Geert van Amerongen, Judith M A van den Brand, Ron A M Fouchier, Albert D M E Osterhaus, Guus F Rimmelzwaan

Publikováno v: PLoS ONE, Vol 4, Iss 5, p e5538 (2009)

Annual vaccination against seasonal influenza viruses is recommended for certain individuals that have a high risk for complications resulting from infection with these viruses. Recently it was recommended in a number of countries including the USA t

Externí odkaz: https://doaj.org/article/b01a9f9d26db4428b9470b14db091c9b

Zobrazit plný text záznamu

Differential Recognition of Influenza A Viruses by M1(58-66) Epitope-Specific CD8(+) T Cells Is Determined by Extraepitopic Amino Acid Residues

Autor: Martina M. Geelhoed-Mieras, Carolien E. van de Sandt, Nella J. Nieuwkoop, Joost H. C. M. Kreijtz, David A. M. C. van de Vijver, Monique I. J. Spronken, Albert D. M. E. Osterhaus, Guus F. Rimmelzwaan, Ron A. M. Fouchier

Publikováno v: Journal of Virology, 90(2), 1009-1022. American Society for Microbiology

Natural influenza A virus infections elicit both virus-specific antibody and CD4 + and CD8 + T cell responses. Influenza A virus-specific CD8 + cytotoxic T lymphocytes (CTLs) contribute to clearance of influenza virus infections. Viral CTL epitopes c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cce8b12ac2a3afb0340fd1deb6da204
https://hdl.handle.net/1765/86469

Zobrazit plný text záznamu

Virus replication kinetics and pathogenesis of infection with H7N9 influenza virus in isogenic guinea pigs upon intratracheal inoculation

Autor: Joost H. C. M. Kreijtz, Lidewij Wiersma, Geert van Amerongen, Mechtild Ladwig, Thijs Kuiken, Albert D. M. E. Osterhaus, Stefanie Banneke, Hubert Schaefer, Stella E. Vogelzang-van Trierum, Guus F. Rimmelzwaan, Peter van Run, Ron A. M. Fouchier

Publikováno v: Vaccine, 33(49), 6983-6987. Elsevier

Since 2013, avian influenza viruses of subtype H7N9 have been transmitted from poultry to humans in China and caused severe disease. Concerns persist over the pandemic potential of this virus and further understanding of immunity and transmission is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65cc9173653565c235f6c49ceb6f7aa1
https://doi.org/10.1016/j.vaccine.2015.08.050

Zobrazit plný text záznamu

Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis

Autor: Eric Claassen, Esther Pronker, Albert D. M. E. Osterhaus, Joost H. C. M. Kreijtz, Bahar Ramezanpour

Publikováno v: Vaccine
Ramezanpour, B, Pronker, E S, Kreijtz, J H C M, Osterhaus, A D M E & Claassen, E 2015, ' Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis. ', Vaccine, vol. 33, no. 35, pp. 3349-3358 . https://doi.org/10.1016/j.vaccine.2015.04.086
Vaccine, 33(35), 3349-3358. Elsevier BV
Vaccine, 33(35), 4349-4358. Elsevier

A quantitative method is presented to rank strengths, weaknesses, opportunities, and threats (SWOT) of modified vaccinia virus Ankara (MVA) as a platform for pre-pandemic and pandemic influenza vaccines. Analytic hierarchy process (AHP) was applied t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ce06f056e355d8653cea1fd312bd73a
https://doi.org/10.1016/j.vaccine.2015.04.086

Zobrazit plný text záznamu

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine

Autor: Asisa Volz, Ron A. M. Fouchier, Guus F. Rimmelzwaan, Michael H. Lehmann, Marco Goeijenbier, Heidi L. M. De Gruyter, Fleur M. Moesker, Albert D. M. E. Osterhaus, David A. M. C. van de Vijver, Gerd Sutter, Gerrie de Mutsert, Joost H. C. M. Kreijtz, Lennert W. J. van den Dries, Simone Goeijenbier, Eric C. M. van Gorp

Publikováno v: The Lancet Infectious Diseases, 14(12), 1196-207. Lancet Publishing Group

BACKGROUND: Modified vaccinia virus Ankara (MVA) is a promising viral vector platform for the development of an H5N1 influenza vaccine. Preclinical assessment of MVA-based H5N1 vaccines showed their immunogenicity and safety in different animal model

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e19327f7a6eea423dfe59e896ab09d1f
https://doi.org/10.1016/s1473-3099(14)70963-6

Zobrazit plný text záznamu

A Single Immunization With Modified Vaccinia Virus Ankara-Based Influenza Virus H7 Vaccine Affords Protection in the Influenza A(H7N9) Pneumonia Ferret Model

Autor: Geert van Amerongen, Stella E. Vogelzang-van Trierum, Lidewij Wiersma, Joost H. C. M. Kreijtz, Albert D. M. E. Osterhaus, Heidi L. M. De Gruyter, Guus F. Rimmelzwaan, Ron A. M. Fouchier, Koert J. Stittelaar, Gerd Sutter

Publikováno v: Journal of Infectious Diseases, 211(5), 791-800. Oxford University Press

Since the first reports in early 2013, >440 human cases of infection with avian influenza A(H7N9) have been reported including 122 fatalities. After the isolation of the first A(H7N9) viruses, the nucleotide sequences became publically available. Bas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42efa455ff768585a8053eaf1645973e
https://doi.org/10.1093/infdis/jiu528

Zobrazit plný text záznamu

Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine

Autor: Joost H. C. M. Kreijtz, Martina M. Geelhoed-Mieras, David A. M. C. van de Vijver, Guus F. Rimmelzwaan, Bror Morein, Carolien E. van de Sandt, Nella J. Nieuwkoop, Ron A. M. Fouchier, Albert D. M. E. Osterhaus, Stella E. Vogelzang-van Trierum

Publikováno v: Vaccine, 32(43), 5614-5623. Elsevier

Vaccines used against seasonal influenza are poorly effective against influenza A viruses of novel subtypes that may have pandemic potential. Furthermore, pre(pandemic) influenza vaccines are poorly immunogenic, which can be overcome by the use of ad

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eb96e0389fe74b2e3964c77aa2a1c79
https://doi.org/10.1016/j.vaccine.2014.08.003

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání